Thais Milioni Luciano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thais Milioni Luciano has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Sonir Roberto Antonini
University of São Paulo
4 shared publications - Mariana Peduti Halah
Division of Pediatric Endocrinology—Department of Pediatrics, Ribeirão Preto Medical School University of São Paulo Brazil
3 shared publications - Luís Eduardo Cruvinel Pinto
Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo/FMRP-USP , São Paulo
2 shared publications - Raphael Del Roio Liberatore Junior
Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, (SP), Brasil
2 shared publications - Benedito Antônio Lopes da Fonseca
Universidade de São Paulo, Brazil
1 shared publication Camila Freitas Oliveira
Department of Medicine, Medical School, University of Ribeirão Preto, Avenida Costabile Romano, Brazil
1 shared publication
Latest Publications
- 30 June 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (10) , e2300-e2311
From Premature Adrenarche to Adult Metabolic Risk and Hyperandrogenism: A Systematic Review and Meta-Analysis
Context: Idiopathic premature adrenarche (IPA) has been associated with a higher risk of metabolic and reproductive dysfunction, but long-term/adult outcomes remain incompletely known. Objective: To assess the relationship between IPA and metabolic syndrome, as well as polycystic ovarian syndrome, in premenarcheal adolescent and adult women. Methods: We conducted a systematic review and meta-analysis of observational studies reporting outcomes in females with IPA after menarche. Databases were searched through February 2025. Primary outcomes included BMI, insulin resistance markers, and clinical and biochemical markers of hyperandrogenism. Data were pooled using random-effects models. The GRADE approach was applied to assess the certainty of evidence. Results: A total of 21 studies comprising 635 females with IPA and 307 age-matched controls were included. Compared to controls, IPA individuals showed significantly higher BMI (MD: 1.4; CI: 1.0 to 1.9), fasting insulin, and HOMA-IR, indicating persistent insulin resistance. Markers of hyperandrogenism, including Ferriman-Gallwey score, DHEAS, and FAI, were also elevated. Secondary analyses revealed higher triglycerides, lower HDL, increased leptin, and greater carotid intima-media thickness, supporting an early pattern of cardiometabolic risk. GRADE assessment rated most outcomes as low certainty. Conclusion: Women with a history of IPA are at increased risk of long-term insulin resistance and hyperandrogenism, with early signs of adverse cardiometabolic profiles. These findings support the need for long-term monitoring in this population.
- 30 June 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (10) , e2300-e2311
From Premature Adrenarche to Adult Metabolic Risk and Hyperandrogenism: A Systematic Review and Meta-Analysis
Context: Idiopathic premature adrenarche (IPA) has been associated with a higher risk of metabolic and reproductive dysfunction, but long-term/adult outcomes remain incompletely known. Objective: To assess the relationship between IPA and metabolic syndrome, as well as polycystic ovarian syndrome, in premenarcheal adolescent and adult women. Methods: We conducted a systematic review and meta-analysis of observational studies reporting outcomes in females with IPA after menarche. Databases were searched through February 2025. Primary outcomes included BMI, insulin resistance markers, and clinical and biochemical markers of hyperandrogenism. Data were pooled using random-effects models. The GRADE approach was applied to assess the certainty of evidence. Results: A total of 21 studies comprising 635 females with IPA and 307 age-matched controls were included. Compared to controls, IPA individuals showed significantly higher BMI (MD: 1.4; CI: 1.0 to 1.9), fasting insulin, and HOMA-IR, indicating persistent insulin resistance. Markers of hyperandrogenism, including Ferriman-Gallwey score, DHEAS, and FAI, were also elevated. Secondary analyses revealed higher triglycerides, lower HDL, increased leptin, and greater carotid intima-media thickness, supporting an early pattern of cardiometabolic risk. GRADE assessment rated most outcomes as low certainty. Conclusion: Women with a history of IPA are at increased risk of long-term insulin resistance and hyperandrogenism, with early signs of adverse cardiometabolic profiles. These findings support the need for long-term monitoring in this population.
- Open Access
- 8 April 2026
- Published by Scientific Scholar in Journal of Pediatric Endocrinology and Diabetes
- Vol. 6, 1-5
Thyroid abscess with transient hyperthyroidism in an adolescent girl –A case report
We report a rare case of thyroid abscess associated with transient hyperthyroidism in a previously healthy adolescent. A 14-year-old girl presented with anterior neck pain progressing to swelling, fever, erythema, asthenia, and weight loss over 12 days. Imaging revealed a large abscess in the left thyroid lobe with tracheal deviation. Laboratory tests showed thyrotoxicosis. The patient underwent two drainage procedures, received antibiotic therapy, and a short course of antithyroid medication, evolving with complete clinical and biochemical recovery. Thyroid abscess should be considered in cases of painful cervical swelling associated with hyperthyroidism, as thyroid function may normalize after appropriate treatment.
- 8 April 2026
- Published by Scientific Scholar in Journal of Pediatric Endocrinology and Diabetes
- Vol. 6, 1-5
Open AccessThyroid abscess with transient hyperthyroidism in an adolescent girl –A case report
We report a rare case of thyroid abscess associated with transient hyperthyroidism in a previously healthy adolescent. A 14-year-old girl presented with anterior neck pain progressing to swelling, fever, erythema, asthenia, and weight loss over 12 days. Imaging revealed a large abscess in the left thyroid lobe with tracheal deviation. Laboratory tests showed thyrotoxicosis. The patient underwent two drainage procedures, received antibiotic therapy, and a short course of antithyroid medication, evolving with complete clinical and biochemical recovery. Thyroid abscess should be considered in cases of painful cervical swelling associated with hyperthyroidism, as thyroid function may normalize after appropriate treatment.
- Open Access
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (5) , 1-11
Quality of life outcomes in Brazilian adults with childhood-onset growth hormone deficiency: impact of transition-age growth hormone therapy
Objective: This study evaluated the QoL of Brazilian adult patients with childhood-onset growth hormone deficiency GHD (CO-GHD), comparing those who continued GH replacement therapy (GHRT) after transition to adulthood with those who discontinued treatment and with healthy subjects. Subjects and methods: In this cross-sectional study, quality of life (QoL) was assessed using the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in 61 Brazilian adults aged 18-50 years. The sample included 31 patients with CO-GHD confirmed during the transition period, who continued or discontinued GHRT, and 30 matched controls. Results: GHD patients had poorer QoL, as indicated by higher QoLAGHDA scores than controls (median 8 [IQR 5-14] vs 4 [IQR 2-8]; p < 0.01). Continued GHRT in adulthood did not impact QoL compared with discontinued GHRT (8 [IQR 6-16] vs. 9 [IQR 5-12], p = 0.33). Overall, women had lower QoL irrespective of GHD (9 [IQR 6-13] vs. 5 [IQR 2-8.5], p = 0.01, women and men, respectively). We found no association between QoL-AGHDA scores and education level (p = 0.51), short stature (p = 0.78), associated pituitary deficiencies (p = 0.34), or overweight/obesity (p = 0.16). Conclusion: GHD impairs quality of life in young adults; however, our cross-sectional cohort did not show significant improvements in quality of life associated with GH replacement therapy. A multidisciplinary approach combining individualized treatment and psychosocial interventions remains essential.
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (5) , 1-11
Open AccessQuality of life outcomes in Brazilian adults with childhood-onset growth hormone deficiency: impact of transition-age growth hormone therapy
Objective: This study evaluated the QoL of Brazilian adult patients with childhood-onset growth hormone deficiency GHD (CO-GHD), comparing those who continued GH replacement therapy (GHRT) after transition to adulthood with those who discontinued treatment and with healthy subjects. Subjects and methods: In this cross-sectional study, quality of life (QoL) was assessed using the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in 61 Brazilian adults aged 18-50 years. The sample included 31 patients with CO-GHD confirmed during the transition period, who continued or discontinued GHRT, and 30 matched controls. Results: GHD patients had poorer QoL, as indicated by higher QoLAGHDA scores than controls (median 8 [IQR 5-14] vs 4 [IQR 2-8]; p < 0.01). Continued GHRT in adulthood did not impact QoL compared with discontinued GHRT (8 [IQR 6-16] vs. 9 [IQR 5-12], p = 0.33). Overall, women had lower QoL irrespective of GHD (9 [IQR 6-13] vs. 5 [IQR 2-8.5], p = 0.01, women and men, respectively). We found no association between QoL-AGHDA scores and education level (p = 0.51), short stature (p = 0.78), associated pituitary deficiencies (p = 0.34), or overweight/obesity (p = 0.16). Conclusion: GHD impairs quality of life in young adults; however, our cross-sectional cohort did not show significant improvements in quality of life associated with GH replacement therapy. A multidisciplinary approach combining individualized treatment and psychosocial interventions remains essential.
- Open Access
- 31 December 2025
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 58 (3)
Perfil clínico e laboratorial de crianças com suspeita de diabetes monogênico
Introdução: O Diabetes mellitus (DM) é uma condição clínica comum com múltiplas apresentações, sendo o diagnóstico diferencial entre diabetes tipo 1, tipo 2 e Maturity Onset Diabetes of the Young (MODY) um desafio frequente. MODY é uma forma rara de diabetes monogênico, caracterizada por um padrão hereditário distinto e critérios diagnósticos específicos. Objetivo: Este estudo visa descrever o perfil clínico e laboratorial de pacientes com suspeita de MODY atendidos no Ambulatório de Diabetes Infantil (AENDI) do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP (HC-FMRP-USP). Métodos: Estudo transversal retrospectivo realizado entre 2012 e 2022, com análise de 12 prontuários de pacientes com suspeita de MODY acompanhados no AENDI. Foram coletados dados demográficos, antropométricos, sintomas, tratamento, exames laboratoriais e histórico familiar, além da aplicação da calculadora de predição para MODY. As análises foram realizadas utilizando estatísticas descritivas. Resultados: Dos pacientes acompanhados no AENDI, apenas 1,25% foram classificados com suspeita de MODY. Nenhum paciente da amostra foi diagnosticado com obesidade. Polidipsia, polifagia, poliúria e perda de peso foram observados em 22,22%, 25%, 44,44% e 28,57% dos casos, respectivamente. A terapia medicamentosa não foi necessária em 66,67% dos pacientes; quando indicada, 50% necessitam de antidiabético oral. A média de glicemia de jejum e hemoglobina glicada foi de 128 mg/dL e 6,02%, respectivamente. Histórico familiar de diabetes em familiares de primeiro e segundo grau foi positivo em 91,66% dos casos. A análise molecular dos genes associados ao MODY foi realizada, mas os resultados ainda não estão disponíveis. Conclusão: Os achados sugerem que a calculadora de predição para MODY é uma ferramenta útil na triagem de pacientes com alta probabilidade de MODY. A criação de protocolos específicos para o rastreamento e acompanhamento desses pacientes é essencial para assegurar um diagnóstico preciso e um manejo clínico adequado.
- 31 December 2025
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 58 (3)
Open AccessPerfil clínico e laboratorial de crianças com suspeita de diabetes monogênico
Introdução: O Diabetes mellitus (DM) é uma condição clínica comum com múltiplas apresentações, sendo o diagnóstico diferencial entre diabetes tipo 1, tipo 2 e Maturity Onset Diabetes of the Young (MODY) um desafio frequente. MODY é uma forma rara de diabetes monogênico, caracterizada por um padrão hereditário distinto e critérios diagnósticos específicos. Objetivo: Este estudo visa descrever o perfil clínico e laboratorial de pacientes com suspeita de MODY atendidos no Ambulatório de Diabetes Infantil (AENDI) do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP (HC-FMRP-USP). Métodos: Estudo transversal retrospectivo realizado entre 2012 e 2022, com análise de 12 prontuários de pacientes com suspeita de MODY acompanhados no AENDI. Foram coletados dados demográficos, antropométricos, sintomas, tratamento, exames laboratoriais e histórico familiar, além da aplicação da calculadora de predição para MODY. As análises foram realizadas utilizando estatísticas descritivas. Resultados: Dos pacientes acompanhados no AENDI, apenas 1,25% foram classificados com suspeita de MODY. Nenhum paciente da amostra foi diagnosticado com obesidade. Polidipsia, polifagia, poliúria e perda de peso foram observados em 22,22%, 25%, 44,44% e 28,57% dos casos, respectivamente. A terapia medicamentosa não foi necessária em 66,67% dos pacientes; quando indicada, 50% necessitam de antidiabético oral. A média de glicemia de jejum e hemoglobina glicada foi de 128 mg/dL e 6,02%, respectivamente. Histórico familiar de diabetes em familiares de primeiro e segundo grau foi positivo em 91,66% dos casos. A análise molecular dos genes associados ao MODY foi realizada, mas os resultados ainda não estão disponíveis. Conclusão: Os achados sugerem que a calculadora de predição para MODY é uma ferramenta útil na triagem de pacientes com alta probabilidade de MODY. A criação de protocolos específicos para o rastreamento e acompanhamento desses pacientes é essencial para assegurar um diagnóstico preciso e um manejo clínico adequado.
- Open Access
- 19 September 2025
- Published by Elsevier in Jornal de Pediatria
- Vol. 101 (6) , 101429
Boys with constitutional delay of growth and puberty developed spontaneous puberty and reached standard adult height without pharmacological therapy
- 19 September 2025
- Published by Elsevier in Jornal de Pediatria
- Vol. 101 (6) , 101429
Open AccessBoys with constitutional delay of growth and puberty developed spontaneous puberty and reached standard adult height without pharmacological therapy
- Open Access
- 17 January 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (1) , 88-91
DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic
We assess the severity and frequency of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes mellitus (T1D) patients and in patients with previous diagnosis of T1D in a referral Brazilian university hospital in the first five months of the COVID-19 pandemic. We also compare the data with data from pre-pandemic periods. Forty-three new-onset T1D patients were diagnosed between April and August of the years 2017, 2018, 2019, and 2020. During the COVID-19 pandemic, the number of new-onset T1D was [...] ABSTRACT We assess the severity and frequency of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes mellitus (T1D) patients and in patients with previous diagnosis of T1D in a referral Brazilian university hospital in the first five months of the COVID-19 pandemic. We also compare the data with data from pre-pandemic periods. Forty-three new-onset T1D patients were diagnosed between April and August of the years 2017, 2018, 2019, and 2020. During the COVID-19 pandemic, the number of new-onset T1D was
- 17 January 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (1) , 88-91
Open AccessDKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic
We assess the severity and frequency of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes mellitus (T1D) patients and in patients with previous diagnosis of T1D in a referral Brazilian university hospital in the first five months of the COVID-19 pandemic. We also compare the data with data from pre-pandemic periods. Forty-three new-onset T1D patients were diagnosed between April and August of the years 2017, 2018, 2019, and 2020. During the COVID-19 pandemic, the number of new-onset T1D was [...] ABSTRACT We assess the severity and frequency of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes mellitus (T1D) patients and in patients with previous diagnosis of T1D in a referral Brazilian university hospital in the first five months of the COVID-19 pandemic. We also compare the data with data from pre-pandemic periods. Forty-three new-onset T1D patients were diagnosed between April and August of the years 2017, 2018, 2019, and 2020. During the COVID-19 pandemic, the number of new-onset T1D was